362 related articles for article (PubMed ID: 26470815)
21. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
Geremia A; Arancibia-Cárcamo CV; Fleming MP; Rust N; Singh B; Mortensen NJ; Travis SP; Powrie F
J Exp Med; 2011 Jun; 208(6):1127-33. PubMed ID: 21576383
[TBL] [Abstract][Full Text] [Related]
22. Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.
Buela KA; Omenetti S; Pizarro TT
Curr Opin Gastroenterol; 2015 Nov; 31(6):449-55. PubMed ID: 26398682
[TBL] [Abstract][Full Text] [Related]
23. Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks.
Han L; Wang XM; Di S; Gao ZZ; Li QW; Wu HR; Wang Q; Zhao LH; Tong XL
Mediators Inflamm; 2019; 2019():1978094. PubMed ID: 30804706
[TBL] [Abstract][Full Text] [Related]
24. Cytokine blockade in inflammatory bowel diseases.
Perrier C; Rutgeerts P
Immunotherapy; 2011 Nov; 3(11):1341-52. PubMed ID: 22053885
[TBL] [Abstract][Full Text] [Related]
25. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
26. Innate Lymphoid Cells in Intestinal Inflammation.
Geremia A; Arancibia-Cárcamo CV
Front Immunol; 2017; 8():1296. PubMed ID: 29081776
[TBL] [Abstract][Full Text] [Related]
27. The immune response in inflammatory bowel disease.
Brown SJ; Mayer L
Am J Gastroenterol; 2007 Sep; 102(9):2058-69. PubMed ID: 17561966
[TBL] [Abstract][Full Text] [Related]
28. miRNAs as new molecular insights into inflammatory bowel disease: Crucial regulators in autoimmunity and inflammation.
Xu XM; Zhang HJ
World J Gastroenterol; 2016 Feb; 22(7):2206-18. PubMed ID: 26900285
[TBL] [Abstract][Full Text] [Related]
29. TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice.
Marafini I; Monteleone I; Di Fusco D; Cupi ML; Paoluzi OA; Colantoni A; Ortenzi A; Izzo R; Vita S; De Luca E; Sica G; Pallone F; Monteleone G
PLoS One; 2015; 10(5):e0126291. PubMed ID: 25950701
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases.
Olesen CM; Coskun M; Peyrin-Biroulet L; Nielsen OH
Pharmacol Ther; 2016 Mar; 159():110-9. PubMed ID: 26808166
[TBL] [Abstract][Full Text] [Related]
31. Cytokines and inflammatory bowel disease: a review.
McClane SJ; Rombeau JL
JPEN J Parenter Enteral Nutr; 1999; 23(5 Suppl):S20-4. PubMed ID: 10483888
[TBL] [Abstract][Full Text] [Related]
32. Immune mechanisms in chronic inflammatory bowel disease.
Braegger CP; MacDonald TT
Ann Allergy; 1994 Feb; 72(2):135-41. PubMed ID: 8109803
[TBL] [Abstract][Full Text] [Related]
33. Role of cytokines in the pathogenesis of inflammatory bowel disease.
Papadakis KA; Targan SR
Annu Rev Med; 2000; 51():289-98. PubMed ID: 10774465
[TBL] [Abstract][Full Text] [Related]
34. New therapies for inflammatory bowel disease: from the bench to the bedside.
Danese S
Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827
[TBL] [Abstract][Full Text] [Related]
35. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
Satokari R
Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease requires the interplay between innate and adaptive immune signals.
Shi D; Das J; Das G
Cell Res; 2006 Jan; 16(1):70-4. PubMed ID: 16467877
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in biological therapy for inflammatory bowel disease.
Kurtovic J; Segal I
Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
[TBL] [Abstract][Full Text] [Related]
38. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
39. Human innate lymphoid cells.
Mjösberg J; Spits H
J Allergy Clin Immunol; 2016 Nov; 138(5):1265-1276. PubMed ID: 27677386
[TBL] [Abstract][Full Text] [Related]
40. Expression of pro-inflammatory cytokines by TCR alpha beta+ and TCR gamma delta+ T cells in an experimental model of colitis.
Simpson SJ; Holländer GA; Mizoguchi E; Allen D; Bhan AK; Wang B; Terhorst C
Eur J Immunol; 1997 Jan; 27(1):17-25. PubMed ID: 9021993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
